Christophe Lee

Managing Director - Sun Hung Kai & Co. at Sun Hung Kai & Co.

Christophe Lee serves as the Deputy CEO of Sun Hung Kai Capital Partners Limited, a leading alternative investment firm in Hong Kong, since November 2023. Lee has held various important leadership roles including Board Member at Gracell Biotechnologies and Independent Non-Executive Director at Goldstream Investment since 2019. Previously, Lee was the Founding Partner at JP Asia Partners from April 2017 to October 2023 and Managing Partner & CEO of the Hong Kong office at IDEG until June 2023. As the CEO and Founder of Lotus Asset Management Ltd. from January 2019 to April 2022, Lee contributed significantly to the financial services industry, also serving on the New Business Committee of the Financial Services Development Council from March 2013 to March 2019. Previous experience includes key roles at OrbusNeich, Morgan Stanley, and Sun Hung Kai & Co. Limited, where Lee was CEO of SHK Fund Management from 2000 to 2010. Lee holds a Bachelor of Applied Science from the University of Pennsylvania.

Links

Previous companies

Gracell Biotechnologies logo